Ontogeny and Characterization of Basic Somatomedin Receptors in Rat Placenta*
- 1 February 1985
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 116 (2) , 492-498
- https://doi.org/10.1210/endo-116-2-492
Abstract
The binding of [125I]basic somatomedin (B-SM) (insulin-like growth factor-I/SM-C) in rat placenta was investigated. Low but specific [125I]B-SM binding to placenta was detected in rats from the end of the 2nd wk (14 days) of gestation. The binding increased until .apprx. 17 days of gestation and then reached a plateau. Binding characteristics did not alter during gestation. In contrast to previous observations [125.LAMBDA.]B-SM binding to the tissue was completed more effectively by B-SM than multiplication stimulating activity (a rat counterpart of IGF-II). Insulin competed for the binding at a higher concentration. The Scatcard plot derived from the binding competition data was curvilinear. Autoradiograms of affinity labeled B-SM receptors in placentas at different gestational age subsequent to sodium dodecyl sulfate-gel (7.5%) electrophoresis revealed labeled constituents with approximate MW > 330 K[kilodaltons] and 140 K in the presence of reduction and > 330 K in the absence of the reductant. Detailed analysis of the receptor in term placenta subsequent to 5-13% gradient gel containing sodium dodecyl sulfate revealed 2 more labeled components (MW 250 K and 36 K) irrespective of the reductant. The intensity of the 250 K and 36 K was low compared to 140 K and 330 K components. Apparently, B-SM receptor in rat placenta, similar to human placenta, binds preferentially to type I or 140 K subunit of the 330 K oligomeric SM receptor.This publication has 21 references indexed in Scilit:
- Characterization of a Specific Receptor for Somatomedin C (SM-C) on Cultured Human Lymphocytes: Evidence that SM-C Modulates Homologous Receptor Concentration*Endocrinology, 1980
- Interactions of Insulin-Like Growth Factors I and II and Multiplication-Stimulating Activity with Receptors and Serum Carrier ProteinsEndocrinology, 1980
- Purification of somatomedin-C from human plasma: chemical and biological properties, partial sequence analysis, and relationship to other somatomedinsBiochemistry, 1980
- Purification and Characterization of Multiplication‐Stimulating ActivityEuropean Journal of Biochemistry, 1980
- Radioimmunoassay of a Basic Somatomedin: Comparison of Various Assay Techniques and Somatomedin Levels in Various Sera*Journal of Clinical Endocrinology & Metabolism, 1979
- Purification of a basic somatomedin, from human plasma Cohn fraction IV-1, with physicochemical and radioimmunoassay similarity to somatomedin-C and insulin-like growth factorCanadian Journal of Biochemistry, 1979
- Interaction of cross-linking agents with the insulin effector system of isolated fat cells. Covalent linkage of 125I-insulin to a plasma membrane receptor protein of 140,000 daltons.Journal of Biological Chemistry, 1979
- Insulin‐Like Growth Factors I and II: Some Biological Actions and Receptor Binding Characteristics of Two Purified Constituents of Nonsuppressible Insulin‐Like Activity of Human SerumEuropean Journal of Biochemistry, 1978
- Evidence that Somatomedin-C Is Degraded by the Kidney and Inhibits Insulin DegradationEndocrinology, 1977
- Polypeptides with nonsuppressible insulin-like and cell-growth promoting activities in human serum: isolation, chemical characterization, and some biological properties of forms I and II.Proceedings of the National Academy of Sciences, 1976